Topical application of aprotinin in cardiac surgery

Perfusion

Volumn 17, Issue 5, 2002, Pages 347-351

  Isgro, Frank ^a   Stanisch, Oliver ^a   Kiessling, Arndt H ^a   Gürler, Semih ^a   Hellstern, Peter ^a   Saggau, Werner ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BIOCHEMICAL MARKER; ELASTASE; HEPARIN; INTERLEUKIN 6; MIDAZOLAM; PANCURONIUM; PROTAMINE; PROTHROMBIN; SUFENTANIL; WARFARIN; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE RELEASE; DRUG ADMINISTRATION ROUTE; ENZYME BLOOD LEVEL; FEMALE; GENDER; HUMAN; INFLAMMATION; INTERNAL MAMMARY ARTERY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFUSION; PERICARDIUM; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME; BLEEDING; BLOOD; DRUG EFFECT; HEART SURGERY; METHODOLOGY; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; APROTININ; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; HUMANS; INFLAMMATION; MIDDLE AGED;

EID: 0036376805     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf596oa     Document Type: Article

References (16)

1. Topical aprotinin in cardiac operations
2. Topical use of aprotinin in open heart operations
3. Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (image) trial
4. The efficacy and safety of aprotinin use in cardiac surgery
5. Inhibition of neutrophil L-selectin shedding: A potential anti-inflammatory effect of aprotinin
6. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: Randomized, double-blind, placebo-controlled study in patients receiving aprotinin acid
7. Cardiopulmonary bypass and the inflammatory response: A role for serine protease inhibitors?
8. What is the mechanism of action of aprotinin (reply)?
9. Thrombomodulin, an endothelial anticoagulant; its structure, function and expression
10. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An uptake
11. Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation
12. Influence of high-dose aprotinin on anti-coagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery
13. The lipoprotein-associated coagulation inhibitor
14. Extrinsic pathway inhibitor - The key to feedback control of blood coagulation initiated by tissue thromboplastin
15. Does aprotinin influence endothelial-associated coagulation in cardiac surgery?
16. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood